XML 28 R21.htm IDEA: XBRL DOCUMENT
v3.25.2

Common Stock and Stock-Based Compensation | 6 Months Ended
--- | ---
Jun. 28, 2025
Share-Based Payment Arrangement [Abstract] |
Common Stock and Stock-Based Compensation | M. Common Stock and Stock-Based Compensation Option Activity Information related to stock options under the Restated Employee Equity Incentive Plan and the Equity Plan for Non-Employee Directors is summarized as follows:
|  | Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term in Years |  |  | Aggregate Intrinsic Value (in thousands) |
Outstanding at December 28, 2024 |  |  | 209,794 |  |  | $ | 358.48 |  |  |  |  |  |  |
Granted |  |  | 80,195 |  |  |  | 243.63 |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |
Forfeited/ Expired |  |  | (2,820 | ) |  |  | 262.25 |  |  |  |  |  |  |
Outstanding at June 28, 2025 |  |  | 287,169 |  |  | $ | 327.35 |  |  |  | 5.94 |  |  | $ | 514 |
Exercisable at June 28, 2025 |  |  | 149,301 |  |  | $ | 348.09 |  |  |  | 3.73 |  |  | $ | 514 |
Vested and expected to vest at June 28, 2025 |  |  | 262,662 |  |  | $ | 333.17 |  |  |  | 5.63 |  |  | $ | 514 |
Of the total options outstanding as of June 28, 2025, 40,103 shares were performance-based options for which the performance criteria had yet to be achieved. On March 1, 2025, the Company granted options to purchase an aggregate of 76,919 shares of the Company’s Class A Common Stock to certain officers and other members of senior management. These options have a weighted average fair value and exercise price per share of $117.00 and $243.77, respectively. On May 14, 2025, the Company granted options to purchase an aggregate of 3,276 shares of the Company’s Class A Common Stock to the Company’s non-employee Directors. All of the options vested immediately on the date of the grant. These options have a fair value and exercise price per share of $119.06 and $240.26, respectively. Weighted average assumptions used to estimate fair values of stock options on the date of grants are as follows:
|  | 2025 |
Expected Volatility |  | 40.4% |
Risk-free interest rate |  | 4.3% |
Expected Dividends |  | 0.0% |
Exercise factor |  |  | 2.1 |
Discount for post-vesting restrictions |  | 0.0% |
Non-Vested Shares Activity Information related to vesting activities of restricted stock units and investment share program under the Restated Employee Equity Incentive Plan and restricted stock units under the Equity Plan for Non-Employee Directors is summarized as follows:
|  | Number of Shares |  |  | Weighted Average Fair Value |
Non-vested at December 28, 2024 |  |  | 164,551 |  |  | $ | 328.88 |
Granted |  |  | 125,457 |  |  |  | 234.14 |
Vested |  |  | (42,120 | ) |  |  | 358.39 |
Forfeited |  |  | (23,336 | ) |  |  | 304.64 |
Non-vested at June 28, 2025 |  |  | 224,552 |  |  | $ | 272.94 |
Of the total non-vested shares as of June 28, 2025, 85,209 shares were performance-based shares for which the performance criteria had yet to be achieved. On March 1, 2025, the Company granted a combined 111,580 shares of restricted stock units to certain officers, other member of senior management and key employees. Of the restricted stock units granted, 61,182 had performance-based vesting criteria. The remainder of restricted stock units granted on March 1, 2025 vest ratably over service periods of four years. Additionally, on March 1, 2025, employees elected to purchase a combined 12,251 shares under the Company’s investment share program. The weighted average fair value of the restricted stock units and investment shares, which are sold to employees at discount under its investment share program, was $243.77 and $145.64 per share, respectively. On May 14, 2025, the Company granted a combined 1,626 shares of restricted stock units to the Company’s non-employee Directors, of which all shares vest one year from the grant date. The fair value of the restricted stock units was $240.26 per share. Stock-Based Compensation The following table provides information regarding stock-based compensation expense included in operating expenses in the accompanying condensed consolidated statements of comprehensive operations:
|  | Thirteen weeks ended |  |  | Twenty-six weeks ended |
|  | June 28, 2025 |  |  | June 29, 2024 |  |  | June 28, 2025 |  |  | June 29, 2024 |
|  | (in thousands) |  |  | (in thousands) |
Amounts included in advertising, promotional and selling expenses |  | $ | 1,764 |  |  | $ | 1,465 |  |  | $ | 4,005 |  |  | $ | 3,930 |
Amounts included in general and administrative expenses |  |  | 3,290 |  |  |  | 2,416 |  |  |  | 6,919 |  |  |  | 7,078 |
Total stock-based compensation expense |  | $ | 5,054 |  |  | $ | 3,881 |  |  | $ | 10,924 |  |  | $ | 11,008 |
Stock Repurchases In 1998, the Company began a share repurchase program. Under this program, the Company's Board of Directors has authorized the repurchase of the Company's Class A Stock. On October 2, 2024, the Board of Directors authorized an increase in the aggregate expenditure limit for the Company’s stock repurchase program by $400.0 million, increasing the limit from $1.2 billion to $1.6 billion. The Board of Directors did not specify a date upon which the total authorization would expire and, in the future, can further increase the authorized amount. Share repurchases under this program for the periods included herein were effected through open market transactions. During the thirteen and twenty-six weeks ended June 28, 2025, the Company repurchased and subsequently retired 217,426 and 418,673 shares of its Class A Common Stock, respectively, for an aggregate purchase price of $49.9 million and $99.1 million, respectively. As of June 28, 2025, the Company had repurchased a cumulative total of approximately 15.3 million shares of its Class A Common Stock for an aggregate purchase price of approximately $1.27 billion and had approximately $328 million remaining on the $1.6 billion stock repurchase expenditure limit set by the Board of Directors.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration